Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# # robots.txt # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html User-agent: * Crawl-delay: 10 # CSS, JS, Images Allow: /misc/*.css$ Allow: /misc/*.css? Allow: /misc/*.js$ Allow: /misc/*.js? Allow: /misc/*.gif Allow: /misc/*.jpg Allow: /misc/*.jpeg Allow: /misc/*.png Allow: /modules/*.css$ Allow: /modules/*.css? Allow: /modules/*.js$ Allow: /modules/*.js? Allow: /modules/*.gif Allow: /modules/*.jpg Allow: /modules/*.jpeg Allow: /modules/*.png Allow: /profiles/*.css$ Allow: /profiles/*.css? Allow: /profiles/*.js$ Allow: /profiles/*.js? |
Title | The Pharma & Biotech Patent Litigation Summit, Europe |
Description | Workshop The European Summit on Pharma and Biotech Patent Litigation will be back in January 2023 for 3 days of practical discussion around the leading industry topics. Our internationally recognised summit will provide you with the necessary practical tools |
Keywords | N/A |
WebSite | pharmabiotechpatentlitigation.com |
Host IP | 104.21.13.163 |
Location | United States |
Site | Rank |
US$650,336
Last updated: 2023-05-18 06:57:23
pharmabiotechpatentlitigation.com has Semrush global rank of 16,275,148. pharmabiotechpatentlitigation.com has an estimated worth of US$ 650,336, based on its estimated Ads revenue. pharmabiotechpatentlitigation.com receives approximately 75,039 unique visitors each day. Its web server is located in United States, with IP address 104.21.13.163. According to SiteAdvisor, pharmabiotechpatentlitigation.com is safe to visit. |
Purchase/Sale Value | US$650,336 |
Daily Ads Revenue | US$601 |
Monthly Ads Revenue | US$18,010 |
Yearly Ads Revenue | US$216,112 |
Daily Unique Visitors | 5,003 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
pharmabiotechpatentlitigation.com. 300 IN A | A | IP: 104.21.13.163 | |
pharmabiotechpatentlitigation.com. 300 IN A | A | IP: 172.67.156.202 | |
pharmabiotechpatentlitigation.com. 300 IN AAAA | AAAA | IPV6: 2606:4700:3033::ac43:9cca | |
pharmabiotechpatentlitigation.com. 300 IN AAAA | AAAA | IPV6: 2606:4700:3030::6815:da3 | |
pharmabiotechpatentlitigation.com. 86400 IN NS | NS | NS Record: norm.ns.cloudflare.com. | |
pharmabiotechpatentlitigation.com. 86400 IN NS | NS | NS Record: lola.ns.cloudflare.com. | |
pharmabiotechpatentlitigation.com. 300 IN MX | MX | MX Record: 5 _dc-mx.2d3bd8beb59f.pharmabiotechpatentlitigation.com. |
Toggle navigation REGISTER YOUR INTEREST UPC PRE DAY WHY ATTEND 2024 PARTNERS VENUE CONTACT US View All Partners Reviewing First UPC Decisions and their Impact on In-House Patent Litigation Strategy, Join Europe’s Leading Pharmaceutical and Biotech Legal Community to Define, Shape and Create Successful Patent Strategies and Mitigate Risks Register Your Interest Anantara Grand Hotel, Amsterdam 22-24 January, 2024 Register Your Interest View the full video “With an ever-changing IP landscape and the imminent arrival of the UPC, now is the time to join the Pharma and Biotech Patent Litigation summit.” Fred Grumitt, Event Director --> RETURNING FOR 2024 The European Summit on Pharma and Biotech Patent Litigation will be back in January 2024 for 3 days of practical discussion around the leading industry topics. Our internationally recognised summit will provide you with the necessary practical tools to both defend patent litigation challenges for your pharma and biotech product, whilst |
HTTP/1.1 301 Moved Permanently Date: Thu, 26 May 2022 20:55:09 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Thu, 26 May 2022 21:55:09 GMT Location: https://pharmabiotechpatentlitigation.com/ Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=5YDfAtoUcutLzPuzP3zQtKXSmoOevKZmjwl2xprDyLTnBOYIwtBMIDjWgXjjzUpHluv8Ekj5GOFXBZY8F%2F9vjmyHrRrY7hGfDNSl4jcVNXKYJ3khyhM7pYbHx7ZtDCfrMphiddeo8CNt67TY4KyX4YD5sQy50veSxwQ%2BjjpzzbY%3D"}],"group":"cf-nel","max_age":604800} NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} Server: cloudflare CF-RAY: 711968fc2fb09b80-FRA alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400 HTTP/2 301 date: Thu, 26 May 2022 20:55:09 GMT content-type: text/html location: https://pharmabiotechpatentlitigation.com/events/patent-litigation-summit x-eventsite: patent-litigation-summit cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=IPHsoYR1jm3009WDepx9wFmyK2GLIXfUXTrT1qgXkdzzJXZXaBuIzXs0YX%2FqVdWQhTYnYSvXJH0atoS%2BQwfpwrDD%2BaqXkbq1r5aggD5l62j7142hMb06w3iVhtMsFuASwqWp9VP3spPdmbymQUqGrNgN%2FxVJi4W5EdiJVr%2Fwx9w%3D"}],"group":"cf-nel","max_age":604800} nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} server: cloudflare cf-ray: 711968fcb8d85c50-FRA alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400 HTTP/2 200 date: Thu, 26 May 2022 20:55:11 GMT content-type: text/html; charset=utf-8 expires: Sun, 19 Nov 1978 05:00:00 GMT cache-control: no-cache, must-revalidate x-content-type-options: nosniff content-language: en x-frame-options: SAMEORIGIN permissions-policy: interest-cohort=() x-generator: Drupal 7 (http://drupal.org) link: ; rel="canonical",; rel="shortlink" vary: Accept-Encoding x-eventsite: patent-litigation-summit cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=qcAhdeWBWsXqGFL0RzIkIwiRtirihqn3TpwXwaaMC9swfvw0wWEyADUQVjmgfZcr2BjQY%2Ftgim6LKmynF4JYcsIs8QV9lit9%2Fgoe%2BHAoGipBrFlxjyMmam%2BNv0ZL22eNeezZWyuHSOWcOoY1J%2B5bNIB3dK2kM7kKSD8eYIoSm4k%3D"}],"group":"cf-nel","max_age":604800} nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} server: cloudflare cf-ray: 711968ff7f805c50-FRA alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400 |
Domain Name: PHARMABIOTECHPATENTLITIGATION.COM Registry Domain ID: 2625479159_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ascio.com Registrar URL: http://www.ascio.com Updated Date: 2021-08-26T15:37:12Z Creation Date: 2021-07-09T15:58:08Z Registry Expiry Date: 2023-07-09T15:58:08Z Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA Registrar IANA ID: 106 Registrar Abuse Contact Email: abuse@ascio.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: LOLA.NS.CLOUDFLARE.COM Name Server: NORM.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2022-05-26T22:15:10Z <<< |